FDA Inspection
Rocky Mountain Apothecary DBA Rocky Mountain PharmacyRocky Mountain Apothecary DBA Rocky Mountain Pharmacy – FDA Inspection, Mar 13, 2018
Record Details
This FDA Inspection record concerns Rocky Mountain Apothecary DBA Rocky Mountain Pharmacy, with an inspection on March 13, 2018, issued by the Seattle District Office, covering human drugs.
- Inspection Date
- March 13, 2018
- Product Type
- Human Drugs
View Company Profile
ID · 233be7da-5fd6-4b5b-83e0-9bb77d4fef8e
Inspection Facts
- Inspection number
- 1045205
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.84(d)(6)Microbiological Contamination Exam
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rocky Mountain Apothecary DBA Rocky Mountain Pharmacy
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 13, 2026 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| September 10, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Rocky Mountain Apothecary DBA Rocky Mountain Pharmacy
- FDA Inspection 1308332 - 2026-03-13
- FDA Inspection 1153894 - 2021-09-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.